ASAP Develops AI Platform for Intelligent Analysis and Management of Insulin Therapy Safety

ASAP has developed a next-generation AI platform for drug safety, created in partnership with the Medical University of Sofia, transforming the way information on insulin therapies is analyzed and managed.

The platform leverages advanced artificial intelligence technologies to convert complex and fragmented medical data into accessible, structured, and actionable information in real time. The solution is designed for both healthcare professionals and patients, significantly improving informed decision-making and enhancing medication safety.

Insulin therapies are critical for the treatment of diabetes but require working with large volumes of data – dosages, contraindications, drug interactions, and adverse reactions. This information is often distributed across multiple regulatory and medical sources, creating a risk of delays or gaps in analysis.

ASAP’s AI platform addresses this challenge through automated processing and intelligent structuring of data from authoritative sources such as SmPC documents and patient leaflets. Through an intuitive chat interface, users can ask questions in natural language and receive precise, context-aware answers based on validated medical information.

Key advantages of the solution:

• AI-powered intelligent assistant for drug information search and analysis
• Automated processing and structuring of medical documents
• Detection of potential drug interactions and safety risks
• Generation of proactive safety alerts
• Digital reporting and analysis of adverse drug reactions

The platform enables the input of individual therapy profiles, using AI to generate personalized alerts and recommendations. This creates an intelligent digital environment that supports pharmacovigilance and enhances therapy safety.

In the long term, ASAP plans to expand the platform to additional therapeutic areas, integrate it with hospital and national healthcare systems, and leverage accumulated data for scientific research and predictive analytics in medicine.

“AI is fundamentally transforming how we work with medical information. With this platform, we are not just digitizing processes – we are building an intelligent system that actively supports risk detection and improves the quality of therapies,” commented the CEO of ASAP.

About ASAP
ASAP is a Bulgarian technology company specializing in the development of large-scale software solutions for the public sector. The company combines deep expertise in system architecture with the implementation of AI technologies to create innovative, secure, and regulation-compliant digital platforms.

About Medical University of Sofia
Medical University of Sofia is a leading academic and research institution in Bulgaria in the fields of medicine and pharmacy, actively developing innovation and scientific research in support of modern healthcare.